Goldstein Advisors, LLC
- SEC CIK
- 0001963807
- Latest filing
- Jul 20, 2026
XERS holding history
Xeris Biopharma Holdings, Inc. in every 13F filed by Goldstein Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
XERS overviewAll 13F holders of XERSFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −40,000−100.0% | Sold out | Holders |
| Q1 2025 | 40,000 | $219.6K | <0.1% | +2,200+5.8% | Added | Holders |
| Q4 2024 | 37,800 | $128.1K | <0.1% | +7,375+24.2% | Added | Holders |
| Q3 2024 | 30,425 | $86.7K | <0.1% | +5,000+19.7% | Added | Holders |
| Q2 2024 | 25,425 | $57.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 25,425 | $56.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 25,425 | $59.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 25,425 | $47.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 25,425 | $66.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 25,425 | $41.4K | <0.1% | +10,000+64.8% | Added | Holders |
| Q4 2022 | 15,425 | $21.0K | <0.1% | – | No prior filing | Holders |